Source link : https://newshealth.biz/health-news/four-year-data-confirm-anifrolumab-efficacy-in-lupus/
Anifrolumab (Saphnelo) is approved for patients with systemic lupus erythematosus (SLE) and its efficacy for symptom relief has been demonstrated for up to 4 years. This study focused on anifrolumab’s long-term effects on hematologic parameters such as hemoglobin, platelets, and white blood cells, as well as SLE serologic biomarkers, in the drug’s clinical trial participants. […]
The post Four-Year Data Confirm Anifrolumab Efficacy in Lupus first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-17 17:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8